In PIONEER 3 and 7, oral semaglutide 7 mg, 14 mg, and flexibly dosed significantly reduced HbA 1c and body weight compared with sitagliptin 100 mg (up to week 52 in PIONEER 7 and week 78 in PIONEER 3) [7, 10]
Any hard walled sealable container works if you do not have a medical one
Gentle yet effective, it delivers daily exfoliation with hydration and soothing benefits
GLP-1 patches would be developed primarily for type 2 diabetes mellitus and obesity management, working through improved glycaemic control, reduced appetite, increased satiety, and delayed gastric emptying, similar to current injectable GLP-1 medications
If you carry variants associated with higher inflammatory responses, your provider may preferentially recommend acetaminophen, topical NSAIDs, or physical therapyreducing the need for high-risk oral NSAID use during your treatment course